Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chris Bieniarz"'
Autor:
Sandra Ehser, Brian D. Kelly, Lauren B. Murata, Jim Ranger-Moore, Koji Tsuta, Thomas M. Grogan, Katie White, Crystal Schemp, Shalini Singh, Penny Towne, Abigail McElhinny, Hiroaki Nitta, Steffan N. Ho, Chris Bieniarz, Akihiko Yoshida, Hitoshi Tsuda, Jerry Kosmeder
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 8(8)
Introduction: The demonstration of anaplastic lymphoma kinase (ALK) positivity in non–small-cell lung cancer (NSCLC) has been hindered by the technical complexity and interpretative challenges of fluorescence in situ hybridization methods for detec
Autor:
Janice Riley, Eric May, Chris Bieniarz, David Jiang, Ubaradka Sathyanarayana, Phil Miller, Gary Pestano, Jeanne Richard, Raymond B. Nagle, Mark Lefever, Adrian E. Murillo, Jerry Kosmeder, Dea Nagy, Michael Farrell, Ashley Santa-Cruz
Publikováno v:
The FASEB Journal. 23
Autor:
Jerome W. Kosmeder, Gary Pestano, Kristie A. Vanpatten, Julia Ashworth-Sharpe, Anne Carpenter, Mark Lefever, Ned C. Haubein, Chris Bieniarz, Janice Riley, John Palting, Scott Lett, Philip Miller
Publikováno v:
The FASEB Journal. 22
Autor:
Jim Ranger-Moore, Thomas M. Grogan, Nikolaus Wick, Isaac Bai, Patrick Brunhoeber, Shalini Singh, Brian D. Kelly, Mary Padilla, Hitoshi Tsuda, Hiroaki Nitta, Chris Bieniarz
Publikováno v:
Diagnostic Pathology
Diagnostic Pathology, Vol 7, Iss 1, p 60 (2012)
Diagnostic Pathology, Vol 7, Iss 1, p 60 (2012)
Background The eligibility of breast cancer patients for human epidermal growth factor receptor 2 (HER2)-directed therapies is determined by the HER2 gene amplification and/or HER2 protein overexpression status of the breast tumor as determined by in
Autor:
Anne Carpenter, Julie Chatigny, Mark LeFever, Julia Ashworth-Sharpe, Ned Haubein, Kristie Vanpatten, Jerry Kosmeder, Scott Lett, Thomas Grogan, Chris Bieniarz, Philip Miller, Gary Pestano
Publikováno v:
The Journal of Immunology. 178:S246-S246
Analyses of biomarkers in tissues represent a critical component in the development of therapeutics. In drug development, entire signaling pathways are profiled with a variety of high-throughput techniques. However, in the field of histology, tissue-